Dr. Anita N. Demas, MD

Dr. Demas practices at California Pacific Medical Center in San Francisco, California.

Dr. Demas' NPI, 1174646012, was assigned on April 7, 2007. Dr. Demas graduated from UCSF School of Medicine in 1997. Dr. Demas holds California license A66065.

Dr. Demas' primary practice is California Pacific Medical Center, at 2340 Clay St, San Francisco, CA 94115 in San Francisco County. The practice phone is (917) 553-7684.

Dr. Demas' primary practice is California Pacific Medical Center in San Francisco, California. Dr. Demas is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is Pacific Heights Medical Group. Dmand AI also links Dr. Demas to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demas practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Demas' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Demas is board certified in internal medicine by the American Board of Internal Medicine. Dr. Demas is licensed in California.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute sinusitis, acute skin infection, adjustment disease, alcohol use disorders, alzheimer's disease and aneurysm among the conditions Dr. Demas treats.

CMS data shows 11,513 Medicare services from Dr. Demas across 45 procedure codes in 2024, for 337 Medicare patients. Medicare paid $623,213 for them. Every service was in an office.

CMS counts 337 Medicare patients who saw Dr. Demas in 2024. The largest group is 75 to 84, with 146 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Demas' median patient age at 66, with 60% women.

In 2024, Dr. Demas wrote 1,897 Medicare Part D claims for 291 patients. 82% of them were for generic drugs. CMS names the drug for 1,513 of them, across 37 drugs with 11 or more claims each, at $106,210 in total drug cost. In 2023, CMS named 1,709 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Demas for performance year 2024, reported as part of a group. Dr. Demas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Demas as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Demas. Dr. Demas' most frequent co-author is Michael Keith Gould, MD, MS.

CMS Open Payments shows 19 general payments to Dr. Demas from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $109.

Dr. Demas graduated from UCSF School of Medicine in 1997.

Dr. Demas is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.